Is Genetic Medicine the Future of Cancer Treatment?

Read Transcript

It's part of the future, there are certain cancers that are driven by an individual molecular abnormality, we target it we can buy time, we don't cure it but we can buy time whether be it months, whether it be a year, whether be it two years, but those are relatively rare in the big scale of things.

Most cancer is driven by multiple molecular drivers. So the wind that we all hear about that make the front page of The New York Times, in general they are a sub, subsection of lung cancer or a small section of leukemia their not the broader section of cancer. And so while they are remarkable wins and big fetes for science, we have to do better in the broader scheme of things and I'd really believe it is going to be a new way.

And there are technologies behind DNA. DNA in my mind is like standing in front of two Chinese restaurants and if we show you the ingredient list, they are exactly the same, that does not tell you anything of what the food is like. So we need to know what the food is like. What DNA in those ingredients list it doesn't tell you what's going on that moment in time it just tells your predisposition, it tells you what their genetic stuff is.

That moment in time there's technology is like proteomics where you can take a drop of blood and look at all the proteins and that's a snapshot in time. Well then there's going to metabolomics. There's then going to be Microbiomics. You have tenfold more bacteria in your body than you do cells in the body.

And so all of a sudden the technology to be able to quantitate them and to interrogate them has become online in the last several years, and we're going to start to understand them and manipulate them going forward. It's going to be exciting.